KLEW Novartis drug Afinitor gets EU nod for breast cancer. Full ArticleReuters IndiaThe drug is the first in a class known as mTOR inhibitors to be approved for post-menopausal women with advanced hormone-receptor positive, HER2-negative breast cancer….
CNBC.comNovartis drug AfinitorR approved by European Commission to treat patients with …ReutersBasel, July 30, 2012 -The European Commission has approved Afinitor R (everolimus) tablets* for the treatment of hormone receptor-positive (HR+), HER2/neu-…
CNBC.comNovartis drug Afinitor wins EU nod to treat breast cancerCNBC.comThe drug is the first in a class known as mTOR inhibitors to be approved for post-menopausal women with advanced hormone-receptor positive, HER2-negative breast cancer. American h…
Novartis drug Afinitor® approved by European Commission to treat patients with …MarketWatch (press release)The approval was based on the Phase III BOLERO-2 (Breast cancer trials of OraL EveROlimus-2) trial[1]. The randomized, double-blind, placebo-c…
Cholesterol-lowering drugs can help in asthma treatment: studyBusiness StandardThe research studied 479 patients on statins and inhaled corticosteroids, and 958 just taking corticosteroids. At least one asthma-related hospitalisation was observed in 3….
Daily MailBoost for asthma patients as researchers discover new breakthrough for …Daily MailA study suggests those taking the cholesterol-lowering drugs statins alongside inhaled corticosteroids are half as likely to require hospital attention. Resea…
Salix and Progenics Receive Complete Response Letter from FDA for …MarketWatch (press release)… AZASAN(R) (Azathioprine) Tablets, USP, 75/100 mg, ANUSOL-HC(R) 2.5% (Hydrocortisone Cream, USP), ANUSOL-HC(R) 25 mg Suppository (Hydrocortisone Acetate)…
TCTMDRESET Published: Comparable Efficacy, Safety with EES, SES at 1 YearTCTMDIn patients with stable coronary artery disease (CAD), the use of either everolimus-eluting stents (EES) or sirolimus-eluting stents (SES) results in low rates of both target…
Sirolimus has anti-skin cancer effect in kidney transplant patientsNews-Medical.netSwitching from calcineurin inhibitors (tacrolimus and cyclosporin) to a sirolimus-containing immunosuppression regimen may help reduce the incidence of secondary skin ca…
Drug Cut Skin Cancers After TransplantMedPage TodayNote that in this study, switching from calcineurin inhibitors to sirolimus had an anti-tumoral effect over a 2-year period among kidney-transplant recipients with previous squamous-cell carcinoma. ……